Skip to main content
Equibles

Allianz Asset Management GmbH

Position in ZTS — Zoetis Inc.

CIK 1535323 MUNICH, 2M
Back to ZTS Full portfolio

Position in ZTS

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$66,488,158
-$13,262,847 QoQ
Shares Held
562,458
-11.3% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 91.54639101941834.ToString("F0")% Shared 0.ToString("F0")% None 8.453608980581661.ToString("F0")%

Common Shares in ZTS Over Time

Shares Held

Position Value (USD)

Derivatives in ZTS

reported options exposure · as of Mar 31, 2026
CallValue
$2,671,546
CallShares
22,600
PutValue
$3,936,393
PutShares
33,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Allianz Asset Management GmbH holds $150,576,236 across 12 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (44.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
This page 		562,458 $66,488,158
2 UTHR
UNITED THERAPEUTICS Corp
 37,748 $22,383,808
3 TEVA
Teva Pharmaceutical Industries Ltd
 568,512 $17,123,580
4 HCM
HUTCHMED (China) Ltd
 837,475 $12,528,626
5 ELAN
Elanco Animal Health Inc
 469,046 $11,224,270
6 VTRS
Viatris Inc
 550,739 $7,440,483
7 EBS
Emergent BioSolutions Inc.
 469,566 $3,897,397
8 HIMS
Hims & Hers Health, Inc.
 166,476 $3,456,041

All Filings in ZTS

Export CSV
42 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $66,488,158 562,458
2026-03-31 $3,936,393 33,300
2026-03-31 $2,671,546 22,600
2025-12-31 $3,661,362 29,100
2025-12-31 $4,139,478 32,900
2025-12-31 $79,751,005 633,850
2025-09-30 $3,701,896 25,300
2025-09-30 $90,634,850 619,429
2025-09-30 $2,867,872 19,600
2025-06-30 $126,326,361 810,044
2025-06-30 $4,257,435 27,300
2025-06-30 $3,056,620 19,600
2025-03-31 $4,873,640 29,600
2025-03-31 $4,215,040 25,600
2025-03-31 $142,702,976 866,705
2024-12-31 $2,574,294 15,800
2024-12-31 $993,873 6,100
2024-12-31 $163,457,727 1,003,239
2024-09-30 $5,236,184 26,800
2024-09-30 $2,891,624 14,800
2024-09-30 $213,796,321 1,094,259
2024-06-30 $179,793,388 1,037,110
2024-06-30 $2,080,320 12,000
2024-06-30 $1,716,264 9,900
2024-03-31 $50,763 300
2024-03-31 $67,684 400
2024-03-31 $110,951,670 655,704
2023-12-31 $151,680,816 768,510
2023-09-30 $151,263,430 869,430
2023-06-30 $162,577,603 944,066
2023-03-31 $150,846,901 906,314
2022-12-31 $140,768,307 960,548
2022-09-30 $142,811,276 963,054
2022-06-30 $421,455,714 2,451,892
2022-03-31 $445,161,789 2,360,474
2021-09-30 $449,952,646 2,317,671
2021-06-30 $406,361,519 2,180,519
2021-03-31 $367,872,176 2,335,993
2020-12-31 $390,587,613 2,360,046
2020-09-30 $376,236,593 2,275,120
2020-06-30 $276,736,519 2,019,385
2020-03-31 $234,453,896 1,992,131

Report a Problem

Category
Description
Email (optional, for follow-up)